Lansforsakringar Fondforvaltning AB publ Increases Position in CVS Health Corporation $CVS

Lansforsakringar Fondforvaltning AB publ grew its stake in CVS Health Corporation (NYSE:CVS) by 2.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 398,612 shares of the pharmacy operator’s stock after acquiring an additional 8,992 shares during the quarter. Lansforsakringar Fondforvaltning AB publ’s holdings in CVS Health were worth $30,051,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Harbor Capital Advisors Inc. raised its holdings in CVS Health by 72.1% in the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after buying an additional 142 shares during the last quarter. Corundum Trust Company INC bought a new stake in shares of CVS Health during the third quarter valued at approximately $29,000. Front Row Advisors LLC raised its holdings in CVS Health by 436.5% in the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after acquiring an additional 371 shares during the last quarter. Twin Peaks Wealth Advisors LLC purchased a new stake in CVS Health during the 2nd quarter valued at $36,000. Finally, SOA Wealth Advisors LLC. increased its holdings in shares of CVS Health by 36.9% in the 3rd quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock worth $37,000 after purchasing an additional 131 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

CVS Health Price Performance

Shares of CVS Health stock opened at $76.64 on Monday. The stock has a market cap of $97.50 billion, a P/E ratio of 55.53, a P/E/G ratio of 0.80 and a beta of 0.50. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.63 and a current ratio of 0.84. The stock’s fifty day moving average is $78.52 and its 200 day moving average is $76.87. CVS Health Corporation has a one year low of $58.35 and a one year high of $85.15.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The business had revenue of $105.69 billion during the quarter, compared to analysts’ expectations of $103.67 billion. During the same quarter in the prior year, the business posted $1.19 earnings per share. The business’s quarterly revenue was up 8.2% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Sell-side analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd were given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.5%. The ex-dividend date was Thursday, January 22nd. CVS Health’s dividend payout ratio is presently 192.75%.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the company. TD Cowen increased their price objective on CVS Health from $100.00 to $105.00 and gave the company a “buy” rating in a research report on Wednesday, December 10th. Barclays lifted their price target on shares of CVS Health from $87.00 to $93.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 10th. UBS Group restated an “outperform” rating on shares of CVS Health in a research report on Wednesday, December 10th. Argus cut their target price on shares of CVS Health from $91.00 to $90.00 and set a “buy” rating for the company in a research report on Wednesday, January 28th. Finally, Sanford C. Bernstein reissued a “market perform” rating and set a $91.00 price target on shares of CVS Health in a report on Tuesday, January 6th. Nineteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, CVS Health presently has an average rating of “Moderate Buy” and a consensus price target of $94.91.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.